Existing medical imaging modalities such as magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and nuclear medicine are finding new applications through the development of specialized imaging reagents. These reagents include organ-specific contrast media and radiopharmaceuticals. At the same time, the digitalization of medical images has enabled extraordinary developments in the analysis, archiving, and sharing of image data.
Image analysis is entering a new era with novel software tools to improve accuracy of diagnosis and to combine data from more than one imaging modality. Systems for the storage and communication of images are changing the way medicine is practiced. The recent Olympics games provided a testing ground for the technology. Several hundred scans were conducted on-site each week and the data was transmitted to remote specialists for rapid and accurate diagnosis. Image management and communications systems are streamlining long-distance collaboration among medical specialists.
SCOPE OF STUDY
REPORT HIGHLIGHTS
A detailed analysis of medical imaging, including supporting products that have enhanced imaging at the chemical (reagents and contrast media) and analytical (software tools and image management) levels
Regulatory aspects important to the industry
Market forecasts based on historical and current data, with five-year projections to 2011, including the U.S. market for medical imaging by technology, and the U.S. market for imaging products, by medical application
An examination of existing technology, the latest innovations and important patents
Profiles of the top companies within the industry.
The U.S. market for medical imaging reagents and analysis tools is valued at a little more than $4.9 billion in 2006 and is expected to grow at an average annual growth rate of 11.9% to reach over $8.4 billion in 2011.
Imaging reagents currently comprise the largest segment with a value of $2.97 billion in 2006. Medical imaging reagents are expected to increase at an average annual rate of 10.5% to reach $4.9 billion in 2011. The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents was over $1 billion in 2006 and is expected to grow with an average annual rate of 11.8% to surpass $1.7 billion in 2011. Ultrasound imaging reagents are expected to experience the most significant growth with an average annual rate of 36% to reach $252.8 million in 2011.
Within the image analysis market, tools for the analysis of ultrasound images were $190.5 million in 2006 and are expected to grow at an average annual rate of 13.6% to reach $360.6 in 2011.
(0 items)
